BofA lowered the firm’s price target on Procter & Gamble to $170 from $175 and keeps a Buy rating on the shares. Entering 2026, the largest unresolved question for staples remains consumption growth and valuations remain dispersed across the group, but “there feels little to get them off the sidelines in ’26 until fundamentals signal a greater turning of the tide,” the analyst tells investors in a year-ahead note for the consumer staples group.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble price target lowered to $157 from $165 at JPMorgan
- Aging Demographics Casts Shadow Over Dividend Growth at Procter & Gamble (PG)
- Midday Fly By: Warner Bros. urges investors to reject Paramount bid
- Spotify initiated, Airbnb upgraded: Wall Street’s top analyst calls
- Procter & Gamble upgraded to Buy from Hold at Jefferies